2,071
Views
1
CrossRef citations to date
0
Altmetric
Research Paper

Construction and validation of nomograms for predicting the prognosis of grade 3 endometrial endometrioid adenocarcinoma cancers: a SEER-based study

, , &
Pages 1752-1765 | Received 09 Feb 2021, Accepted 21 Apr 2021, Published online: 11 May 2021

Figures & data

Table 1. Clinical information of OS cohort

Table 2. Clinical information of CSS cohort

Figure 1. Flow chart of analysis

Figure 1. Flow chart of analysis

Table 3. Univariate and multivariate cox analysis in OS

Table 4. Univariate and multivariate cox analysis in CSS

Figure 2. OS survival curves in patients with G3 EACs

Figure 2. OS survival curves in patients with G3 EACs

Figure 3. CSS survival curves in patients with G3 EACs

Figure 3. CSS survival curves in patients with G3 EACs

Figure 4. (a): The OS nomogram model. (b): The CSS nomogram model

Figure 4. (a): The OS nomogram model. (b): The CSS nomogram model

Figure 5. (a): OS calibration diagram in the training set. (b): CSS calibration diagram in the training set. (c): OS calibration diagram in the validation set. (d): CSS calibration diagram in the validation set

Figure 5. (a): OS calibration diagram in the training set. (b): CSS calibration diagram in the training set. (c): OS calibration diagram in the validation set. (d): CSS calibration diagram in the validation set

Figure 6. Clinical utility of the nomogram models in the training set. (a–c): ROC curve of each model at 1, 3, and 5 years (OS). (d–f): DCA curve of each model at 1, 3, and 5 years (OS)

Figure 6. Clinical utility of the nomogram models in the training set. (a–c): ROC curve of each model at 1, 3, and 5 years (OS). (d–f): DCA curve of each model at 1, 3, and 5 years (OS)

Figure 7. (a–c): ROC curve of each model at 1, 3, and 5 years (CSS). (d–f): DCA curve of each model at 1, 3, and 5 years (CSS)

Figure 7. (a–c): ROC curve of each model at 1, 3, and 5 years (CSS). (d–f): DCA curve of each model at 1, 3, and 5 years (CSS)

Figure 8. Clinical utility of the nomogram models in the validation set. (a–c): ROC curve of each model at 1, 3, and 5 years (OS). (d–f): DCA curve of each model at 1, 3, and 5 years (OS)

Figure 8. Clinical utility of the nomogram models in the validation set. (a–c): ROC curve of each model at 1, 3, and 5 years (OS). (d–f): DCA curve of each model at 1, 3, and 5 years (OS)

Figure 9. (a–c): ROC curve of each model at 1, 3, and 5 years (CSS). (d–f): DCA curve of each model at 1, 3, and 5 years (CSS)

Figure 9. (a–c): ROC curve of each model at 1, 3, and 5 years (CSS). (d–f): DCA curve of each model at 1, 3, and 5 years (CSS)
Supplemental material

Supplemental Material

Download ()

Data availability statement

Some or all data, or code generated or used during the study are available from the corresponding author by request.

https://seer.cancer.gov/